EPCAM and prostate cancer: Kuske et al. [24] also reported improved detection of CTCs in nonmetastatic prostate cancer patients by combining 3 independent CTC assays: the CELLSEARCH system, CellCollector, and EPISPOT (an EpCAM-independent enrichment method).